Minami Y, Doki N, Matsuoka H, Yokota T, et al. Asciminib in Patients With CML-CP Previously Treated With >/= 2 Tyrosine Kinase Inhibitors: 96-Week Results From the Japanese Subgroup Analysis of the ASCEMBL Study. Int J Hematol 2024;120:305-313.
PMID: 38888812